Email Alert | RSS

北京大学学报（医学版） ›› 2021, Vol. 53 ›› Issue (6): 1043-1048. doi: 10.19723/j.issn.1671-167X.2021.06.006

• 论著 • 上一篇    下一篇

IgG4相关性疾病中枢神经系统受累的临床特点分析

孟广艳1,2,张筠肖1,3,张渝昕1,刘燕鹰1,4,△   

  1. 1.北京大学人民医院风湿免疫科,北京 100044
    2.北京大学人民医院检验科,北京 100044
    3.北京市监狱管理局清河分局医院内科,天津 300481
    4.首都医科大学附属北京友谊医院风湿免疫科,北京 100050
  • 收稿日期:2021-08-19 出版日期:2021-12-18 发布日期:2021-12-13
  • 通讯作者: 刘燕鹰
  • 基金资助:
    国家自然科学基金(81971520)

Clinical characteristics of central nervous system involvement in IgG4 related diseases

MENG Guang-yan1,2,ZHANG Yun-xiao1,3,ZHANG Yu-xin1,LIU Yan-ying1,4,△   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
    2. Department of Clinical Laboratory, Peking University People’s Hospital, Beijing 100044, China
    3. Department of Internal Medicine, Hospital of Qinghe Branch of Beijing Prison Administration, Tianjin 300481, China
    4. Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
  • Received:2021-08-19 Online:2021-12-18 Published:2021-12-13
  • Contact: Yan-ying LIU
  • Supported by:
    National Natural Science Foundation of China(81971520)

RICH HTML

 9   

PDF (PC)

121

摘要：

目的:提高对IgG4相关性疾病伴有中枢神经系统病变的认识,以早期诊断、早期治疗。方法:回顾性分析10例IgG4相关性疾病伴有中枢神经系统病变患者的临床资料,总结其临床表现、实验室检查、影像学检查、组织病理学及治疗方面的特点。结果:10例IgG4相关性疾病合并中枢神经系统受累的患者中,垂体受累者6例,硬脑膜受累者4例;单纯神经系统受累者仅2例,其余8例患者均合并其他脏器受累;一半患者以神经系统受累为首发表现,神经系统症状多表现为多饮、多尿、头痛、视力下降等。实验室检查中,9例(90.0%)血清IgG4水平升高,血清总IgE升高者7例(87.5%),部分患者血清IgG、血红细胞沉降率、C反应蛋白升高,补体C3、C4下降。8例患者接受了不同部位的组织病理活检,病理检查均可见大量淋巴细胞、浆细胞浸润,部分可见纤维组织增生。所有患者均接受了糖皮质激素治疗,8例(80%)联合了免疫抑制剂治疗,3例因病情反复给予利妥昔单抗治疗。所有患者中,2例(20%)达到完全缓解,8例(80%)部分缓解,中位随访时间13.5个月,复发4例。结论:IgG4相关性疾病的中枢神经系统病变中,垂体、硬脑膜为常见受累部位,大多合并其他脏器受累,但半数患者以神经系统症状为首发表现,因症状不典型,应结合实验室、影像学检查,必要时行组织病理活检明确诊断。

关键词: IgG4相关性疾病, 中枢神经系统, 诊断, 鉴别, 垂体炎, 脑膜炎

Abstract:

Objective: To improve the understanding of the clinical characteristics of immunoglobulin G4-related disease (IgG4-RD) with central nervous system (CNS) involvement, so as to contribute to the early diagnosis and treatment. Methods: In this study, 10 patients with IgG4-RD with CNS involvement were selected. Clinical data including demographic features, clinical manifestations, organ involvement, laboratory findings, radiological results, pathology, treatments and outcomes were collected retrospectively. Results: Among the 10 IgG4-RD patients complicated with CNS involvement, 6 cases manifested as pituitary involvement and 4 cases manifested as dural involvement. Only 2 patients had nervous system involvement alone, while the left patients were complicated with other organ involvement besides nervous system. Half of the patients presented nervous system involvement as the initial manifestation, and the main symptoms of nervous system included polydipsia, polyuria, headache, decreased vision and so on. In the laboratory examination, the serum IgG4 level was increased in 9 cases (90.0%), and the total serum IgE was increased in 7 cases (87.5%). At the same time, their IgG, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were increased, while complement (C) 3 and C4 were decreased in some patients. Eight patients underwent tissue biopsies in different parts, the pathological examination showed a large number of lymphocyte and plasma cell infiltration, accompanied by fibrous tissue proliferation in part. All the patients were treated with glucocorticoids, and 8 cases (80%) were given immunosuppressants at the same time, and 3 cases were treated with rituximab when they expe-rienced disease relapse. As a result, 2 cases (20%) achieved complete remission (CR), and 8 cases (80%) achieved partial remission (PR). The median follow-up time was 13.5 months, and 4 cases relapsed. Conclusion: Pituitary and dura are common affected organs of IgG4-RD with CNS involvement. Most IgG4-RD patients with CNS involvement are combined with other organ involvement, but half of them presented nervous system involvement as the initial manifestation, and the symptoms are not typical. In order to make an early diagnosis, laboratory, imaging examination and tissue biopsy should be taken into consideration in combination if necessary.

Key words: Immunoglobulin G4-related diseases, Central nervous system, Diagnosis, differential, Hypophysitis, Meningitis

中图分类号: 

  • R593.2

表1

10例IgG4-RD患者临床特点分析"

Case Gender Onset age/
years		 Disease
course/years		 Symptom Extra-CNS involvement
Initial symptoms Accompanying symptoms
1 M 53 8.0 Xerophthalmia Thirsty, polydipsia, polyuria,
submandibular masses		 LG, SMG
2 M 58 2.0 Abdominal pain and distension Diarrhea Pancreas
3 M 56 1.0 Epigastric pain Shortness of breath, polydipsia and polyuria Pancreas, lung, pleura,
LN, PG, SMG, BD
4 F 44 12.0 Eyelid swelling Polydipsia, polyuria and shortness of breath Pancreas, lung, kidney,
LG, SMG, PG
5 M 40 23.0 Polydipsia, polyuria Weight loss, lumbago pain Pancreas, kidney, ureter, LN
6 M 43 7.0 Thirsty, polydipsia, polyuria Eyelid swelling LG, LN
7 M 52 7.0 Headache Left facial atrophy Lung
8 M 15 1.0 Eyes pain Headache, vision and hearing loss No
9 M 52 2.5 Eyelid swelling Epilepsy, eye pain, vision loss,
buccal and submandibular swelling		 LG, SMG, PG
10 M 46 1.0 Right ear pain Headache, hoarseness,
muscular atrophy of lower limbs		 No

表2

10例IgG4-RD患者实验室检查结果"

Case WBC/
(×109/L)		 EO% EO/
(×109/L)		 IgE/
(IU/mL)		 IgA/
(g/L)		 IgM/
(g/L)		 IgG/
(g/L)		 IgG4/
(mg/dL)		 C3/
(g/L)		 C4/
(g/L)		 ESR/
(mm/h)		 CRP/
(mg/L)		 ANA
1 13.97 9.3 1.29 359.7 0.94 0.435 31.2 4 370 0.846 0.314 19 3.30 -
2 8.20 1.1 0.09 ND 1.83 0.400 9.5 225 0.780 0.170 2 2.43 -
3 8.10 3.9 0.30 391.0 1.42 0.756 7.3 341 0.858 0.192 3 <0.50 -
4 9.30 2.5 0.20 206.6 1.38 0.627 16.4 1 880 0.748 0.149 8 0.39 1 :80
homogenesis
5 7.06 7.4 0.52 596.8 1.23 0.754 23.2 2 510 0.654 0.238 53 1.80 -
6 DL DL DL 221.0 DL DL DL 3 270 DL DL DL DL DL
7 5.40 1.0 0.10 ND 1.99 0.663 11.7 207 0.900 0.155 2 2.47 -
8 9.79 1.5 0.15 1 040.0 6.74 0.875 18.4 431 0.845 0.166 ND 10.90 -
9 11.20 0.2 0 1 164.0 1.80 0.329 52.7 6 100 0.455 0.040 32 <0.50 -
10 10.70 0.1 0 12.2 0.95 0.754 7.3 153 0.972 0.285 57 90.10 -

图1

IgG4-RD患者影像学检查(头颅MRI)特征"

表3

10例IgG4-RD患者影像学检查、组织病理学检查结果及治疗情况"

Case Imaging examination Histopathology Induction
therapy		 Outcome Follow-up/
month		 Relapse
Biopsy tissue LI TF OP IgG4+/
HPF		 IgG4+/
IgG+
1 Pituitary gland plumped SMG + - - >10 50% GC+CTX PR 76 N
2 Sellar space occupied ND ND ND ND ND ND GC+CTX PR 42 N
3 Pituitary stalk thickened LN + - - >50 20% GC+CTX/RTX PR 14 N
4 Pituitary stalk thickened Pars orbitalis + - - >20 40% GC+CTX/
MMF/RTX		 PR 13 Y
5 Abnormal signal in pituitary, cerebellar tentorium thickened, bilateral cavernous sinus enlarged Pancreas + + + >50 80% GC+AZA CR 108 N
6 Circular nodules in pituitary LN + - - >50 40% GC CR 12 N
7 Dura mater thickened and enhanced, dural nodules Right frontal
parietal lobe		 + + - 30 40% GC+CTX PR 6 N
8 Dura mater thickened, optic nerve thickened ND ND ND ND ND ND GC+RTX PR 48 Y
9 Dura mater thickened, right caver-nous sinus occupied Sious
cavernosus		 + + - 30 40% GC+CTX PR 9 Y
10 Dura mater thickened and enhanced, spinal dura mater thickened Meninges + + - >10 40% GC+CTX PR 5 Y

图2

IgG4-RD患者的组织病理特征(HE ×200)"

[1] Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopatholo-gical entity of IgG4-related autoimmune disease[J]. J Gastroenterol, 2003, 38(10):982-984.
pmid: 14614606
[2] Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021, 31(3):529-533.
doi: 10.1080/14397595.2020.1859710
[3] Peng L, Zhang P, Zhang X, et al. Clinical features of immunoglobulin G4-related disease with central nervous system involvement: An analysis of 15 cases[J]. Clin Exp Rheumatol, 2020, 38(4):626-632.
[4] Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease[J]. Lancet, 2015, 385(9976):1460-1471.
doi: 10.1016/S0140-6736(14)60720-0 pmid: 25481618
[5] 王子乔, 刘燕鹰, 张霞, 等. 17例误诊为IgG4相关疾病患者的临床特点及误诊原因分析[J]. 北京大学学报(医学版), 2019, 51(6):1025-1031.
[6] 朱星昀, 刘燕鹰, 孙学娟, 等. 免疫球蛋白G4相关疾病患者发病形式及就诊行为特征分析[J]. 北京大学学报(医学版), 2018, 50(6):1039-1043.
[7] Iseda I, Hida K, Tone A, et al. Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis[J]. Endocr J, 2014, 61(2):195-203.
doi: 10.1507/endocrj.EJ13-0407
[8] 李芊, 段炼, 李伟, 等. IgG4相关性垂体炎5例临床分析[J]. 中国实用内科杂志, 2018, 38(9):861-864.
[9] Ohkubo Y, Sekido T, Takeshige K, et al. Occurrence of IgG4-related hypophysitis lacking IgG4-bearing plasma cell infiltration during steroid therapy[J]. Intern Med, 2014, 53(7):753-757.
doi: 10.2169/internalmedicine.53.0714
[10] Christakis PG, Machado DG, Fattahi P. Idiopathic hypertrophic pachymeningitis mimicking neurosarcoidosis[J]. Clin Neurol Neurosurg, 2012, 114(2):176-178.
doi: 10.1016/j.clineuro.2011.10.011
[11] 苏玉莹, 王晨琼, 董凌莉. IgG4相关性疾病的发病机制及进展[J]. 中华临床医师杂志:电子版, 2014(14):2713-2717.
[12] 纪宗斐. IgG4相关性疾病(IgG4-RD)发病机制的研究进展[J]. 复旦学报(医学版), 2019, 46(1):114-118.
[13] Leporati P, Landek-Salgado MA, Lupi I, et al. IgG4-related hypophysitis: A new addition to the hypophysitis spectrum[J]. J Clin Endocrinol Metab, 2011, 96(7):1971-1980.
doi: 10.1210/jc.2010-2970 pmid: 21593109
[14] Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing pachymeningitis: A previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease[J]. Am J Surg Pathol, 2009, 33(8):1249-1252.
doi: 10.1097/PAS.0b013e3181abdfc2
[15] Lee YS, Lee HW, Park KS, et al. Immunoglobulin G4-related hypertrophic pachymeningitis with skull involvement[J]. Brain Tumor Res Treat, 2014, 2(2):87-91.
doi: 10.14791/btrt.2014.2.2.87
[16] Peng Y, Li JQ, Zhang PP, et al. Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: A long-term cohort study[J]. J Intern Med, 2019, 286(5):542-552.
doi: 10.1111/joim.12942 pmid: 31121062
[1] 翟莉,邱楠,宋惠. 多中心网状组织细胞增生症1例[J]. 北京大学学报（医学版）, 2021, 53(6): 1183-1187.
[2] 邱敏,费月阳,邓绍晖,刘承,卢剑,何为,陆敏,田晓军,张树栋,马潞林. 后肾腺瘤的诊治经验及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(2): 417-419.
[3] 孟圆,张丽琪,赵雅宁,柳登高,张祖燕,高岩. 67例上颌根尖周囊肿的三维影像特点分析[J]. 北京大学学报（医学版）, 2021, 53(2): 396-401.
[4] 王昱,邓雪蓉,季兰岚,张晓慧,耿研,张卓莉. 超声检测痛风患者肌腱受累的危险因素和诊断价值[J]. 北京大学学报（医学版）, 2021, 53(1): 143-149.
[5] 高璐,谷岩. 中国人群腭中缝形态特点分期与Demirjian牙龄的相关性[J]. 北京大学学报（医学版）, 2021, 53(1): 133-138.
[6] 袁源,郎宁,袁慧书. CT能谱曲线在脊柱转移瘤和感染性病变中的鉴别诊断价值[J]. 北京大学学报（医学版）, 2021, 53(1): 183-187.
[7] 贾园,栗占国. 成人巨噬细胞活化综合征诊断困境和个体化治疗[J]. 北京大学学报（医学版）, 2020, 52(6): 991-994.
[8] 康琦,张继新,高莹,张俊清,郭晓蕙. 100例甲状腺嗜酸细胞腺瘤的诊治分析[J]. 北京大学学报（医学版）, 2020, 52(6): 1098-1101.
[9] 程功,张霞,杨菲,程嘉渝,刘燕鹰. 以发热、关节炎、皮肤色素沉着为主要表现的血管免疫母细胞性T细胞淋巴瘤1例[J]. 北京大学学报（医学版）, 2020, 52(6): 1150-1152.
[10] 赵冬慧,李丹阳,张帆,屈磊,张颖,王素霞,刘刚. 4例重链或轻重链肾淀粉样变性患者的临床病理特点[J]. 北京大学学报（医学版）, 2020, 52(6): 1162-1165.
[11] 柳小珍,李莹莹,杨丽萍. 全外显子组测序和目标序列靶向捕获测序在遗传性视网膜变性基因诊断中的差异[J]. 北京大学学报（医学版）, 2020, 52(5): 836-844.
[12] 罗采南,李正芳,武丽君,陈海娟,杨春梅,徐文晖,刘小玲,唐薇,乔平,热娜·白合提亚. 类风湿关节炎不同分类标准的多中心临床比较[J]. 北京大学学报（医学版）, 2020, 52(5): 897-901.
[13] 刘鹭,田杰,吴恺,高莹,张争,张俊清,郭晓蕙. 血浆游离型甲氧基肾上腺素类物质检测正常的嗜铬细胞瘤和副神经节瘤的临床特点[J]. 北京大学学报（医学版）, 2020, 52(4): 614-620.
[14] 李潇,苏家增,张严妍,张丽琪,张亚琼,柳登高,俞光岩. 131I相关唾液腺炎的炎症分级及内镜治疗[J]. 北京大学学报（医学版）, 2020, 52(3): 586-590.
[15] 王骁,李兆星,范焕芳,魏莉瑛,郭旭瑾,郭娜,王彤. 罕见小肠囊腺瘤1例报道[J]. 北京大学学报（医学版）, 2020, 52(2): 382-384.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张三. 中文标题测试[J]. 北京大学学报（医学版）, 2010, 42(1): 1 -10 .
[2] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报（医学版）, 2009, 41(2): 188 -191 .
[3] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报（医学版）, 2009, 41(3): 376 -379 .
[4] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报（医学版）, 2009, 41(4): 459 -462 .
[5] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报（医学版）, 2010, 42(1): 82 -84 .
[6] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报（医学版）, 2007, 39(3): 319 -322 .
[7] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报（医学版）, 2007, 39(3): 333 -336 .
[8] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报（医学版）, 2007, 39(3): 337 -340 .
[9] . 书讯[J]. 北京大学学报（医学版）, 2007, 39(3): 225 -328 .
[10] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报（医学版）, 2007, 39(4): 346 -350 .
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部